CP-461 is active alone and in combination with gemcitabine, vinorelbine, or irinotecan in non-small cell lung cancer cell lines.

被引：0
|
作者：
Schiller, J
Purvis, J
Bittner, G
机构：
[1] Cell Pathways Inc, Horsham, PA USA
[2] Univ Wisconsin, Madison, WI USA
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
661P
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [1] Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer
    Adjei, AA
    Argiris, A
    Murren, JR
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 32 - 40
  • [2] Gemcitabine and vinorelbine in advanced non-small cell lung cancer
    Vazquez, F
    Cueva, JF
    Baron, FJ
    Candamio, S
    Calvo, M
    Irigoyen, A
    Huidobro, C
    Lopez, R
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [3] Combination chemotherapy of gemcitabine and vinorelbine in patients with advanced non-small cell lung cancer
    Buyukcelik, A
    Utkan, G
    Yalcin, B
    Demirkazik, A
    LUNG CANCER, 2004, 46 (03) : 377 - 378
  • [4] Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer
    Hasturk, S
    Hatabay, N
    Ece, F
    Karatas, M
    Hanta, I
    LUNG CANCER, 2005, 49 : S247 - S247
  • [5] Combination effects of cisplatin, vinorelbine and irinotecan in non-small-cell lung cancer cell lines in vitro
    Mogi, H
    Hasegawa, Y
    Watanabe, A
    Nomura, F
    Saka, H
    Shimokata, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 39 (03) : 199 - 204
  • [6] Single-agent gemcitabine and gemcitabine/irinotecan combination (IrimoGem) in non-small cell lung cancer
    Lima, CMSR
    Eckardt, JR
    Leong, SS
    Sherman, CA
    Perkel, JA
    Putman, T
    Safa, AR
    Bahadori, HR
    Green, MR
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 43 - 50
  • [7] Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancer
    Herbst, RS
    Lilenbaum, R
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 67 - 70
  • [8] Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer
    Nishio, M
    Ohyanagi, F
    Taguch, F
    Matsuda, M
    Sato, Y
    Okumura, S
    Nakagawa, K
    Horai, T
    LUNG CANCER, 2005, 48 (01) : 115 - 119
  • [9] Activity of dianhydrogalactitol alone or with platinum drugs against non-small cell lung cancer cell lines.
    Steino, Anne
    He, Guangan
    Bacha, Jeffrey A.
    Kanekal, Sarath
    Brown, Dennis
    Siddik, Zahid Hussain
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Preclinical study of the cytotoxic effect of nutlin-3a as monotherapy or in combination with gemcitabine in non-small cell lung cancer cell lines.
    Deben, Christophe
    Quix, Celine
    Wouters, An
    Baay, Marc
    Pauwels, Patrick
    Peeters, Marc
    Lardon, Filip
    Deschoolmeester, Vanessa
    CANCER RESEARCH, 2013, 73 (08)
12345